544 related articles for article (PubMed ID: 9934858)
1. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
2. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
4. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
[TBL] [Abstract][Full Text] [Related]
5. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane.
McDougal A; Sethi Gupta M; Ramamoorthy K; Sun G; Safe SH
Cancer Lett; 2000 Apr; 151(2):169-79. PubMed ID: 10738111
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells.
Castro-Rivera E; Wormke M; Safe S
Mol Cell Endocrinol; 1999 Apr; 150(1-2):11-21. PubMed ID: 10411295
[TBL] [Abstract][Full Text] [Related]
10. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
11. Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats.
McDougal A; Gupta MS; Morrow D; Ramamoorthy K; Lee JE; Safe SH
Breast Cancer Res Treat; 2001 Mar; 66(2):147-57. PubMed ID: 11437101
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.
Gupta M; McDougal A; Safe S
J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):413-9. PubMed ID: 10030690
[TBL] [Abstract][Full Text] [Related]
13. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
Liu H; Wormke M; Safe SH; Bjeldanes LF
J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
[TBL] [Abstract][Full Text] [Related]
14. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
Chen I; McDougal A; Wang F; Safe S
Carcinogenesis; 1998 Sep; 19(9):1631-9. PubMed ID: 9771935
[TBL] [Abstract][Full Text] [Related]
16. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521
[TBL] [Abstract][Full Text] [Related]
17. The effect of 6-nitro-1,3,8-trichlorodibenzofuran as a partial estrogen in the female rat uterus.
Dickerson R; Howie L; Safe S
Toxicol Appl Pharmacol; 1992 Mar; 113(1):55-63. PubMed ID: 1313194
[TBL] [Abstract][Full Text] [Related]
18. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T
Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239
[TBL] [Abstract][Full Text] [Related]
19. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
20. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155).
Fielden MR; Chen I; Chittim B; Safe SH; Zacharewski TR
Environ Health Perspect; 1997 Nov; 105(11):1238-48. PubMed ID: 9370515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
